Post-breast cancer, metformin has no effect on mortality

Post-breast cancer, metformin has no effect on mortality
For older women with diabetes and breast cancer, there is no association between metformin use and all-cause or breast cancer-specific mortality, according to a study published online April 30 in Diabetes Care.

(HealthDay)—For older women with diabetes and breast cancer, there is no association between metformin use and all-cause or breast cancer-specific mortality, according to a study published online April 30 in Diabetes Care.

Iliana C. Lega, M.D., from the Women's College Hospital in Toronto, and colleagues conducted a population-based study involving 2,361 women aged 66 years or older diagnosed with diabetes and . The correlation between cumulative duration of past use and all-cause and breast cancer-specific mortality was assessed.

During a mean follow-up of 4.5 years, the researchers identified 1,101 deaths (46.6 percent), of which 16.3 percent were breast cancer-specific. There was no significant association observed between cumulative duration of past metformin use and all-cause or breast cancer-specific mortality.

"In summary, we conducted a large population-based study to investigate the effects of metformin therapy on mortality after breast cancer in a diabetic population," the authors write. "Cumulative exposure of metformin was not significantly associated with all-cause or breast cancer-specific mortality in our incident diabetic cohort when modeled as a time-varying covariate."


Explore further

Popular diabetes drug does not improve survival rates after cancer

More information: Abstract
Full Text (subscription or payment may be required)
Journal information: Diabetes Care

Health News Copyright © 2013 HealthDay. All rights reserved.

Citation: Post-breast cancer, metformin has no effect on mortality (2013, July 3) retrieved 13 November 2019 from https://medicalxpress.com/news/2013-07-post-breast-cancer-metformin-effect-mortality.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments